More than 70 per cent of health care settings provide staff with appropriate insulin training, the latest National Diabetes Inpatient Safety Audit has identified. Dr Alistair Lumb, Consultant in Diabe...
Two diabetes inpatient experts have shared the latest findings from the Diabetes Emergencies: Virtual Interactive Clinical Education (DEVICE) study at this year’s Diabetes UK Professional Conference (...
Healthcare professionals are invited to discover safe injection practices in an upcoming online event hosted by an established diabetes company. embecta will provide diabetes teams with the current re...
Two diabetes professionals are launching an inpatient campaign next month to educate hospital teams caring for people with the condition. Basic inpatient diabetes knowledge will be available to hea...
PolyPhotonix Limited and embecta UK have announced they have signed a co-promotional agreement under which embecta sales representatives will promote PolyPhotonix’s Noctura 400 Sleep Mask to healthcar...
Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per share in cash, representing an equity value of approximately $2.9 billion. The transaction adds an innovative, fully owned, first-in-c...
Individuals living with type 2 diabetes are nearly 20 per cent more likely to die from cancer compared to those without, latest research reveals. The study has also found that people living with type ...
Employees at a pioneering Guildford-based healthcare business are covering the distance it would take to walk around the world to raise funds for a leading diabetes charity. GlucoRx – the UK’s largest...
An established professor has been ranked as one of the world’s top 10 experts for hyperglycaemia. Expertscape.com has recognised Professor Ketan Dhatariya, who works in Norfolk and Norwich University ...